Christian A Thomas Selected Research

Drug Therapy (Chemotherapy)

1/2022	IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain.
11/2020	Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial.
1/2019	Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
1/2019	Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial.
6/2018	Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christian A Thomas Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 02/2005
3	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2018
2	Brain Neoplasms (Brain Tumor) 01/2022 - 09/2014
2	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 06/2018
1	Body Weight Changes 11/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Disease Progression 01/2019
1	Neutropenia 01/2019
1	Carcinoma (Carcinomatosis) 01/2018
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 09/2014
1	Seizures (Absence Seizure) 09/2014
1	Adenocarcinoma of Lung 09/2014
1	Hyponatremia 09/2014
1	Encephalitis (Encephalitis, Rasmussen) 09/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 02/2005

Drug/Important Bio-Agent (IBA)

4	Bevacizumab (Avastin)FDA Link 01/2022 - 06/2018
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2019
3	atezolizumabIBA 01/2022 - 06/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2019
2	Cholecalciferol (Vitamin D3)FDA Link 11/2020 - 01/2019
1	GenieIBA 01/2023
1	Calcitriol Receptors (Calcitriol Receptor)IBA 11/2020
1	Vitamin D FDA LinkGeneric 11/2020
1	25-hydroxyvitamin DIBA 01/2019
1	hydroxide ionIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2018
1	B7-H1 AntigenIBA 06/2018
1	NucleotidesIBA 01/2018
1	Adenosine Monophosphate (AMP)IBA 01/2016
1	Vasopressins (Vasopressin)IBA 09/2014
1	Acyclovir (Aciclovir)FDA LinkGeneric 09/2014
1	Prothrombin (Factor II)IBA 02/2005
1	factor V LeidenIBA 02/2005

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2022 - 06/2018
1	Therapeutics 01/2018
1	Patient Admission (Patient Admissions) 01/2016
1	Radiotherapy 09/2014